TY - JOUR
T1 - Supportive Care Organization in France
T2 - a national in-depth survey among patients and oncologists
AU - Scotté, Florian
AU - Hervé, Christian
AU - Leroy, Pauline
AU - Tourani, Jean Marc
AU - Bensadoun, René Jean
AU - Bugat, Marie Eve
AU - Farsi, Fadila
AU - Jovenin, Nicolas
AU - Namer, Moïse
AU - Tournigand, Christophe
AU - Morin, Sophie
AU - Brami, Cloé
AU - Oudard, Stéphane
AU - Saadi, Alexandre
AU - Krakowski, Ivan
N1 - Publisher Copyright:
© 2017, Springer-Verlag Berlin Heidelberg.
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Purpose: Medical doctors’ (MDs), but not patients’, perception of supportive care in cancer (SCC) in France has been previously assessed in a national survey. This study evaluated MDs and patients’ perceptions of the SCC organization and implementation in France. Methods: The French SCC Association conducted two observational studies: study 1 (S1), containing a 30-point questionnaire sent to 2263 MDs, and study 2 (S2), containing a 40-point questionnaire sent to 2000 patients. Results: Overall, 711 MDs completed S1 and 1562 patients completed S2. In S1, 81% of MDs reported relying on a SCC organization and 76% attended SCC multidisciplinary discussions. MDs considered palliative (98%), psychological (98%), and social care (98%) as the top 3 SCC areas of importance for patients. In contrast, patients’ priorities were psychology (61%), nutrition (55%) and organization of intake consultations (55%). The concept of SCC was familiar to 34% of patients; according to MDs, this concept was introduced mainly by MDs (78%) and admission nurses (41%). Outpatients identified as professional resources for SCC information general practitioners (84%), nurses (58%), and pharmacists (52%). Patients reported supportive treatment being prescribed in 63% of cases, with 64% receiving information on the negative side-effects. Among MDs, 87% reported proposing palliative and 41% adjuvant SCC treatment. Furthermore, 72% of MDs recommended SCC treatment at the metastatic stage, and 36% immediately following diagnosis. Discussion: Oncologists play a vital role in enhancing SCC efficacy. This can be increased by implementing a multidisciplinary integrated approach or by assuring the availability of patient information.
AB - Purpose: Medical doctors’ (MDs), but not patients’, perception of supportive care in cancer (SCC) in France has been previously assessed in a national survey. This study evaluated MDs and patients’ perceptions of the SCC organization and implementation in France. Methods: The French SCC Association conducted two observational studies: study 1 (S1), containing a 30-point questionnaire sent to 2263 MDs, and study 2 (S2), containing a 40-point questionnaire sent to 2000 patients. Results: Overall, 711 MDs completed S1 and 1562 patients completed S2. In S1, 81% of MDs reported relying on a SCC organization and 76% attended SCC multidisciplinary discussions. MDs considered palliative (98%), psychological (98%), and social care (98%) as the top 3 SCC areas of importance for patients. In contrast, patients’ priorities were psychology (61%), nutrition (55%) and organization of intake consultations (55%). The concept of SCC was familiar to 34% of patients; according to MDs, this concept was introduced mainly by MDs (78%) and admission nurses (41%). Outpatients identified as professional resources for SCC information general practitioners (84%), nurses (58%), and pharmacists (52%). Patients reported supportive treatment being prescribed in 63% of cases, with 64% receiving information on the negative side-effects. Among MDs, 87% reported proposing palliative and 41% adjuvant SCC treatment. Furthermore, 72% of MDs recommended SCC treatment at the metastatic stage, and 36% immediately following diagnosis. Discussion: Oncologists play a vital role in enhancing SCC efficacy. This can be increased by implementing a multidisciplinary integrated approach or by assuring the availability of patient information.
KW - Multidisciplinary
KW - National survey
KW - Patient’s opinion
KW - Supportive care
UR - http://www.scopus.com/inward/record.url?scp=85013213513&partnerID=8YFLogxK
U2 - 10.1007/s00520-017-3615-x
DO - 10.1007/s00520-017-3615-x
M3 - Article
C2 - 28220314
AN - SCOPUS:85013213513
SN - 0941-4355
VL - 25
SP - 2111
EP - 2118
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 7
ER -